
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel
Shaopeng Yuan, Jorge Almagro, Elaine Fuchs
Nature reviews. Cancer (2024) Vol. 24, Iss. 4, pp. 274-286
Open Access | Times Cited: 45
Shaopeng Yuan, Jorge Almagro, Elaine Fuchs
Nature reviews. Cancer (2024) Vol. 24, Iss. 4, pp. 274-286
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Aging and cancer
Léa Montégut, Carlos López-Otı́n, Guido Kroemer
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 48
Léa Montégut, Carlos López-Otı́n, Guido Kroemer
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 48
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Complexity made easy: Aggregation‐induced emission small molecules for cancer diagnosis and phototherapies
Luojia Chen, Si‐Ling Chen, Yuncong Yuan, et al.
Aggregate (2024)
Open Access | Times Cited: 11
Luojia Chen, Si‐Ling Chen, Yuncong Yuan, et al.
Aggregate (2024)
Open Access | Times Cited: 11
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 470-470
Open Access | Times Cited: 1
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 470-470
Open Access | Times Cited: 1
Emerging strategies to investigate the biology of early cancer
Ran Zhou, Xiwen Tang, Yuan Wang
Nature reviews. Cancer (2024) Vol. 24, Iss. 12, pp. 850-866
Closed Access | Times Cited: 6
Ran Zhou, Xiwen Tang, Yuan Wang
Nature reviews. Cancer (2024) Vol. 24, Iss. 12, pp. 850-866
Closed Access | Times Cited: 6
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma
Tomás Duraj, Miriam Kalamian, Giulio Zuccoli, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Tomás Duraj, Miriam Kalamian, Giulio Zuccoli, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer
Letizia Lanzetti
Cell Death and Differentiation (2024)
Open Access | Times Cited: 5
Letizia Lanzetti
Cell Death and Differentiation (2024)
Open Access | Times Cited: 5
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer
Antti Kiviaho, Sini K. Eerola, Heini Kallio, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Antti Kiviaho, Sini K. Eerola, Heini Kallio, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 5
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 5
Technological advances in clinical individualized medication for cancer therapy: from genes to whole organism
Jiejing Kai, Xueling Liu, Meijia Wu, et al.
Personalized Medicine (2025), pp. 1-14
Open Access
Jiejing Kai, Xueling Liu, Meijia Wu, et al.
Personalized Medicine (2025), pp. 1-14
Open Access
HVEM as a Tumor-Intrinsic Regulator in Non-Small Cell Lung Cancer: Suppression of Metastasis via Glycolysis Inhibition and Modulation of Macrophage Polarization
Yuanshan Yao, Bin Li, Chunji Chen, et al.
Pharmacological Research (2025), pp. 107604-107604
Open Access
Yuanshan Yao, Bin Li, Chunji Chen, et al.
Pharmacological Research (2025), pp. 107604-107604
Open Access
PERK-Olating Through Cancer: A Brew of Cellular Decisions
Laurent Mazzolini, Christian Touriol
Biomolecules (2025) Vol. 15, Iss. 2, pp. 248-248
Open Access
Laurent Mazzolini, Christian Touriol
Biomolecules (2025) Vol. 15, Iss. 2, pp. 248-248
Open Access
Exposomal determinants of non-genetic plasticity in tumor initiation
Davide Carra, Silvana C. E. Maas, José A. Seoane, et al.
Trends in cancer (2025)
Closed Access
Davide Carra, Silvana C. E. Maas, José A. Seoane, et al.
Trends in cancer (2025)
Closed Access
Graphene oxide–chloroquine conjugate induces DNA damage in A549 lung cancer cells through autophagy modulation
Brahamdutt Arya, Sandeep Mittal, Prachi Joshi, et al.
Beilstein Journal of Nanotechnology (2025) Vol. 16, pp. 316-332
Open Access
Brahamdutt Arya, Sandeep Mittal, Prachi Joshi, et al.
Beilstein Journal of Nanotechnology (2025) Vol. 16, pp. 316-332
Open Access
Biotin Receptor-Targeting PtIV Oxygen Carrying Prodrug Amphiphile for Alleviating Tumor Hypoxia Induced Immune Chemotherapy Suppression
Kaichuang Sun, Xiaodan Wei, Shangcong Han, et al.
ACS Nano (2025)
Closed Access
Kaichuang Sun, Xiaodan Wei, Shangcong Han, et al.
ACS Nano (2025)
Closed Access
Single-Cell Multi-Omics: Insights into Therapeutic Innovations to Advance Treatment in Cancer
Ai-xing Guan, Camelia Quek
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2447-2447
Open Access
Ai-xing Guan, Camelia Quek
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2447-2447
Open Access
Aromatics from fossil fuels and breast cancer
Leena Hilakivi‐Clarke, Theresa Krista Jolejole, Joas Lucas da Silva, et al.
iScience (2025), pp. 112204-112204
Open Access
Leena Hilakivi‐Clarke, Theresa Krista Jolejole, Joas Lucas da Silva, et al.
iScience (2025), pp. 112204-112204
Open Access
A Multifunctional Fluorescent Probe: Selective Visualization of Mitochondria and Tumor Cells with Viscosity/Polarity Responsiveness
Fengjun Hu, Fawei Zhu, Lei Yang, et al.
Sensors and Actuators B Chemical (2025), pp. 137644-137644
Closed Access
Fengjun Hu, Fawei Zhu, Lei Yang, et al.
Sensors and Actuators B Chemical (2025), pp. 137644-137644
Closed Access
IL-1β+ macrophages and the control of pathogenic inflammation in cancer
Nicoletta Caronni, Federica La Terza, Luca Frosio, et al.
Trends in Immunology (2025)
Closed Access
Nicoletta Caronni, Federica La Terza, Luca Frosio, et al.
Trends in Immunology (2025)
Closed Access
Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications
Wenjie Chen, Yingjie Wang
Oncogene (2025)
Closed Access
Wenjie Chen, Yingjie Wang
Oncogene (2025)
Closed Access
Glutathion peroxidase 4 (GPX4) and Ribosomal Protein L40 (RPL40) participate in arsenic induced progression of renal cell carcinoma by regulating the NLRP3 mediated classic pyroptosis pathway
Xiaodan Zhang, Jinyu Li, Jing He, et al.
International Journal of Biological Macromolecules (2025), pp. 143129-143129
Closed Access
Xiaodan Zhang, Jinyu Li, Jing He, et al.
International Journal of Biological Macromolecules (2025), pp. 143129-143129
Closed Access
Recent advances in therapeutic use of transforming growth factor-beta inhibitors in cancer and fibrosis
Jing He, Yan Gao, Linyuan Jing, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jing He, Yan Gao, Linyuan Jing, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Functionalized Niosomes for Co-Delivery of Curcumin and Imatinib Mesylate to Treat Breast Cancer: In Vitro and In Vivo Investigations
Priyadarshi Aparajay, Harishkumar Madhyastha, Mohammad A. Altamimi, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 5
Closed Access
Priyadarshi Aparajay, Harishkumar Madhyastha, Mohammad A. Altamimi, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 5
Closed Access
Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment
Wenqiang Li, Quan Yuan, Mei Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Wenqiang Li, Quan Yuan, Mei Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3